Reductive and bioreductive activation is controlled by electronic properties of substituents in conformationally-constrained anticancer drug delivery systems

Medicinal Chemistry Research

Volumn 10, Issue 3, 2000, Pages 149-163

  Weerapreeyakul, N ^a   Visser, P ^a   Brummelhuis, M ^a   Gharat, L ^a   Chikhale, P J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MELPHALAN; MELPHALAN METHYL ESTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SODIUM BOROHYDRIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ARTICLE; CYCLIC POTENTIOMETRY; CYCLIZATION; DRUG ACTIVATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ELECTRON TRANSPORT; REACTION ANALYSIS; REDUCTION;

EID: 0034541288     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Therapeutic attack of hypoxic cells of solid tumors, presidential address
2. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by the NADPH-cytochrome P-450 reductase and xanthine oxidase
3. Use of hypoxia-directed drugs in the therapy of solid tumors
4. 5 reductase
5. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors
6. DT-Diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines
7. Potential bioreductive alkylating agents. VI. Determination of the relationship between oxidation-reduction potential and antineoplastic activity
8. Hypoxia-selective antitumor agents. 8. Bis (nitroimidazolyl) alkane carboxamides: A new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitizers
9. Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: Potential prodrugs of cyclization activated aromatic mustards
10. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials
11. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck
12. Bioreductive agents: A clinical update
13. Concomittance chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
14. Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells
15. Cancer in focus
16. Delivery of molecular medicine to solid tumors
17. Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug
18. Reductive lactonization of strategically methylated quinone propionic acid esters and amides
19. Tumor targeted prodrugs: Redox-activation of conformationally-constrained, bioreductive melphalan prodrugs
20. Reductive-activation of conformationally-constrained anticancer drug delivery systems
21. Conformational constraint and electronic properties of substituents influence stability of bioreductive drug delivery systems containing melphalan
22. Modulating blood-brain interaction of amino acid-based anticancer agents
23. A bioreversible prodrug approach designed to shift mechanism uptake for amino acid-containing anticancer agents
24. Amine prodrugs which utilize hydroxy amide lactonization. II. A potential esterase-sensitive amide prodrug
25. R possessing in vivo antitumor activity
26. Phosphate prodrugs for amines utilizing a fast intramolecular hydroxy amide lactonization
27. Prodrug strategies based on intramolecular cyclization reactions
28. Intestinal transport and metabolism of novel enkephalin prodrugs
29. Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkers
30. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of the phenylpropionic acid promoiety in a model hexapeptide
31. Hydroxyl group catalysis. IV. The mechanism of intramolecular participation of aliphatic hydroxyl group in amide hydrolysis
32. 2-Acyloxymethylbenzoic acids. Novel amine protective functions providing amides with the lability of esters
33. Formation and hydrolysis of lactones of phenolic acids
34. A novel esterase-sensitive polymeric prodrug system for amine containing drugs
35. Drug delivery systems based on trimethyl lock lactonization: Poly(ethyleneglycol) prodrugs of amino-containing compounds
36. A facilitated cyclic ether formation and its potential application in solid-phase peptide and organic synthesis
37. The methyl esterification of amino acids with 2,2-dimethoxypropane and aqueous hydrogen chloride
38. Potential bioreductive alkylating agents. 5. Antineoplastic activity of quinoline-5,8-diones, napthazarins and naphthoquinones
39. The hypoxic tumor cell, a target for selective cancer chemotherapy
40. Mechanism(s) of bioreductive activation. The example of diaziquinone (AZQ)
41. Modified extraction and chromatography for the measurement of plasma melphalan by ion-pair high-performance liquid chromatography
42. Nicotinamide Adenine dinucleotide (phosphate): Quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines
43. Reductase enzymes expression across the National Cancer Institute Tumor Cell Line Panel: Correlation with sensitivity to mitomycin C and EO9